Dr Susan Renee Anderson-jones, MD | |
2525 Glenn Hendren Dr, Pain Management, Liberty, MO 64068-9625 | |
(816) 781-7200 | |
(816) 781-6973 |
Full Name | Dr Susan Renee Anderson-jones |
---|---|
Gender | Female |
Speciality | Interventional Pain Management |
Experience | 30 Years |
Location | 2525 Glenn Hendren Dr, Liberty, Missouri |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1932182763 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207LP2900X | Anesthesiology - Pain Medicine | 106273 (Missouri) | Secondary |
208VP0014X | Pain Medicine - Interventional Pain Medicine | 106273 (Missouri) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
New Liberty Hospital District | Liberty, MO | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
New Liberty Hospital Corporation | 9931166618 | 95 |
News Archive
Thank parasites for making some of our immune proteins into the inflammatory defenders they are today, according to a population genetics study that will appear in the June 8 issue of the Journal of Experimental Medicine (online May 25).
Adults and children with asthma will breathe deeper and have better control over their asthma with inhaled corticosteroids than with the medicine cromolyn, according to a new review of recent studies comparing the two treatments.
Genzyme Corp. today announced that the results from its Late-Onset Treatment Study have been published in today's New England Journal of Medicine. The study was undertaken to evaluate the safety and efficacy of Myozyme (alglucosidase alfa) in older children and adults with Pompe disease.
Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced that it will convene a Tissue Diagnostics Patient Safety Advisory Board on February 27 at its headquarters in Tucson, Arizona.
› Verified 1 days ago
Entity Name | New Liberty Hospital Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1669734661 PECOS PAC ID: 9931166618 Enrollment ID: O20120918000321 |
News Archive
Thank parasites for making some of our immune proteins into the inflammatory defenders they are today, according to a population genetics study that will appear in the June 8 issue of the Journal of Experimental Medicine (online May 25).
Adults and children with asthma will breathe deeper and have better control over their asthma with inhaled corticosteroids than with the medicine cromolyn, according to a new review of recent studies comparing the two treatments.
Genzyme Corp. today announced that the results from its Late-Onset Treatment Study have been published in today's New England Journal of Medicine. The study was undertaken to evaluate the safety and efficacy of Myozyme (alglucosidase alfa) in older children and adults with Pompe disease.
Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced that it will convene a Tissue Diagnostics Patient Safety Advisory Board on February 27 at its headquarters in Tucson, Arizona.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Susan Renee Anderson-jones, MD Po Box 219672, Kansas City, MO 64121-9672 Ph: (816) 781-7200 | Dr Susan Renee Anderson-jones, MD 2525 Glenn Hendren Dr, Pain Management, Liberty, MO 64068-9625 Ph: (816) 781-7200 |
News Archive
Thank parasites for making some of our immune proteins into the inflammatory defenders they are today, according to a population genetics study that will appear in the June 8 issue of the Journal of Experimental Medicine (online May 25).
Adults and children with asthma will breathe deeper and have better control over their asthma with inhaled corticosteroids than with the medicine cromolyn, according to a new review of recent studies comparing the two treatments.
Genzyme Corp. today announced that the results from its Late-Onset Treatment Study have been published in today's New England Journal of Medicine. The study was undertaken to evaluate the safety and efficacy of Myozyme (alglucosidase alfa) in older children and adults with Pompe disease.
Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced that it will convene a Tissue Diagnostics Patient Safety Advisory Board on February 27 at its headquarters in Tucson, Arizona.
› Verified 1 days ago